Skip to main content

Justin Holko

Head of Investor Relations

Regeneron Pharmaceuticals, Inc. (REGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About Justin Holko

Justin Holko is recorded as Head of Investor Relations at Regeneron Pharmaceuticals, Inc. (REGN). Justin Holko has spoken on 2 earnings calls across 1 company, most recently for Regeneron Pharmaceuticals, Inc. on November 4, 2021. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

Justin Holko on recent calls

“Thank you for your interest in Regeneron Pharmaceuticals, and welcome to the Third Quarter 2021 Conference Call. An archive of this webcast will be available on our website.”
Head of Investor Relations, Regeneron Pharmaceuticals, Inc. Q3 FY2021 Earnings Call ·
“Thank you for your interest in Regeneron Pharmaceuticals, and welcome to the second quarter 2021 conference call. An archive of this webcast will be available on our website.”
Head of Investor Relations, Regeneron Pharmaceuticals, Inc. Q2 FY2021 Earnings Call ·

Affiliation history

Company network

Leadership on record at Regeneron Pharmaceuticals, Inc.

Recent activity